Aberrant CYP2D6 metabolizer phenotypes do not show increased frequency in patients undergoing ECT after antidepressant therapy

Author(s):
Mirzakhani, H.; Dormolen, J. van; Weide, K. van der; Guchelaar, H.J. (0000-0002-7085-1383); Noorden, M.S. van; Swen, J.
Published
2015
Publication type
Article / Letter to editor
CYP2D6 genotypeselectroconvulsive therapymetabolizer phenotypespharmacogeneticstreatment-resistant depression
Date issued
2015-10-31
Language
English
Is part of
Pharmacogenetics and Genomics (2015), Vol. 25, no. 10, p. 515-517
hdl
1887/102783
doi
10.1097/FPC.0000000000000167